These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
488 related items for PubMed ID: 33236174
1. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole. Torchelsen FKVDS, Silva TM, Milagre MM, Silva RR, Reis LES, Branquinho RT, Silva GN, de Lana M. Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174 [Abstract] [Full Text] [Related]
2. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models. Gulin JEN, Eagleson MA, López-Muñoz RA, Solana ME, Altcheh J, García-Bournissen F. Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923 [Abstract] [Full Text] [Related]
4. Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon. Teston APM, Fernandes NS, Abegg CP, de Abreu AP, Sarto MPM, Gomes ML, Toledo MJO. Exp Parasitol; 2021 Sep; 228():108136. PubMed ID: 34280400 [Abstract] [Full Text] [Related]
5. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach. Strauss M, Rodrigues JHS, Lo Presti MS, Bazán PC, Báez AL, Paglini-Oliva P, Nakamura CV, Bustamante JM, Rivarola HW. Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395 [Abstract] [Full Text] [Related]
6. Thioridazine aggravates skeletal myositis, systemic and liver inflammation in Trypanosoma cruzi-infected and benznidazole-treated mice. Mendonça AAS, Gonçalves-Santos E, Souza-Silva TG, González-Lozano KJ, Caldas IS, Gonçalves RV, Diniz LF, Novaes RD. Int Immunopharmacol; 2020 Aug; 85():106611. PubMed ID: 32447223 [Abstract] [Full Text] [Related]
7. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease. García MC, Ponce NE, Sanmarco LM, Manzo RH, Jimenez-Kairuz AF, Aoki MP. Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322 [Abstract] [Full Text] [Related]
8. Impact of gastrointestinal inoculation and benznidazole treatment on infection by Trypanosoma cruzi (Y strain, DTU TcII) in Swiss mice. Lucas da Silva HF, Sarto MPM, de Abreu AP, Fernandes NS, Santos IGMD, de Souza Trovo JV, da Silva AF, Souza-Kaneshima AM, Comar JF, Toledo MJO. Exp Parasitol; 2024 Oct; 265():108810. PubMed ID: 39134115 [Abstract] [Full Text] [Related]
9. Preclinical evaluation of combined therapy with amiodarone and low-dose benznidazole in a mouse model of chronic Trypanosoma cruzi infection. Barbosa JMC, Pedra-Rezende Y, Mata-Santos HA, Vilar-Pereira G, Melo TG, Ramos IP, Gibaldi D, Moreira OC, Nunes DF, Batista MM, Lannes-Vieira J, Daliry A, Salomão K. Biomed Pharmacother; 2024 Jun; 175():116742. PubMed ID: 38754265 [Abstract] [Full Text] [Related]
11. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV. Zanusso Junior G, Massago M, Kian D, Toledo MJO. Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891 [Abstract] [Full Text] [Related]